Musle biopsy

90
Muscle biopsy Dr Neha Mahajan

description

Useful for postgraduate students in Pathology.

Transcript of Musle biopsy

Page 1: Musle biopsy

Muscle biopsy

Dr Neha Mahajan

Page 2: Musle biopsy

Normal Muscle

Page 3: Musle biopsy

Organization of Skeletal Muscle Including Connective Tissue (CT) Compartments

EPIMYSIUM•Loose CT

•Blood vessels

PERIMYSIUM

•Septa

•Nerve branches

•Muscle spindles

•Fat

•Blood vessels

ENDOMYSIUM

•Muscle fibers

•Capillaries

•Small nerve fibers

Page 4: Musle biopsy

Perimysial

connective tissue

Endomysial

connective tissue

Normal H&E-stained frozen cross-section of skeletal muscle

Note uniform sizes, polygonal shapes, and eccentric nuclei.

Page 5: Musle biopsy

Normal muscle Adult Normal Muscle child

Page 6: Musle biopsy
Page 7: Musle biopsy

Ultrastructure of a Sarcomere

Extends from Z-band to Z-band.

Note arrangement of thick and thin filaments.

Z ZM

H band

Actin

MyosinI bandI band

A band

A band includes overlap of actin & myosin.

Page 8: Musle biopsy

Indications of Muscle biopsy

General reasons:Weakness of uncertain cause-generalised, proximal ,floppy infant syndromeMuscle pain ,cramps, stiffnessPersistently elevated muscle enzymes(CK)Specific reasons:Hereditary muscle disease in other family membersCarrier detectionSystemic connective tissue disease & vasculitisCertain metabolic diseases such as storage diseaseSuspicion of steroid myopathy in treated myositisExclude drug induced myopathyConflicting clinical ,EMG or lab findingsConfirm/reinforce clinical diagnosis

Page 9: Musle biopsy

Contraindications

1.Electrolyte disturbance2.Most endocrine 3.Malignant hyperthermia4.Periodic paralysis5.Poor nutrition6.Prior Trauma

Page 10: Musle biopsy

Site of biopsy

• Muscle with moderate disease, NOT severe

• Muscle belly, not from tendon

• Proximal myopathies/generalised systemic disease- Vastus Lateralis

• Other sites-Biceps,gatronemius

• Avoid Deltoid,muscle that are site of EMG,injections/trauma

• Imaging used to select pathological muscle site in difficult cases.

Page 11: Musle biopsy

Bergston NeedleTechnique

1.Needle Biopsy

2.Open Biopsy- indicated for disorders with patchy pathology

Page 12: Musle biopsy

Processing

Transportation:Muscle may be saved in saline moistened guage for several hrsKeep the specimen coolDo NOT immerse in saline ,fixative or other liquid

Fresh Fixed

Glutaraldehyde

RESIN section/EM( 1mm x 0.5 cm)

Formalin

PARAFFIN(0.5x0.5cm)

Snap freeze

HISTOCHEMISTRY(0.5x0.5cm)

Page 13: Musle biopsy

Sample size: 0.5 cm diameter & 1 1cm length

Biopsy is processed:

1.Paraffin embedding2.Histochemistry3.For electron microscopy4.For molecular biology

Page 14: Musle biopsy

Stains1. H&E- gen architecture & morphology2.Masson`s trichome-Collagen,fibrosis3.Mod Gomori`s Trichome- red ragged fibres,nemaline

bodies,nuclei,myelinated fibres4.PAS-glycogen5.Oil red O-neutral lipid6.Acid phosphatase-lysosomal enzymes,necrotic fibres7.Crystal voilet, Congo Red-amyloid8.ATPase PH 9.4 Type 1 fibres pale

Type 2 fibres dark9. ATPase PH 4.6 Type 1 fibres dark

Type 2 fibres pale10. NADH- Sarcoplasmic structural details11.SDH- oxidative enzyme activity12.Cytochrome C Oxidase- mitochondrial enzyme activity13.NSE-lysosomal &macrophage activity

Page 15: Musle biopsy

Type I fibers are light

Type II fibers are dark

Normal ATPase pH 9.4

Page 16: Musle biopsy

Rapid gomori`s trichomestainRed ragged fibers,nemalinebodies,myelinated fibers

Nuclei :red purpleNormal muscle myofibrils:BlueGreenIntermyofibril muscle membrane: RedInterstitial collagen: Green

Page 17: Musle biopsy

NADH-TR stainSarcoplasmic structural

details

Page 18: Musle biopsy

SDH stainFor mitochondrial activity

Page 19: Musle biopsy

Cytochrome c oxidase•Mitochondrial activity•Type 1 fibers are darkerthan Type2

Page 20: Musle biopsy

OIL RED OAccumulation of lipid

Page 21: Musle biopsy

Esterase stainLysosomal & phagocytic activity

Macrophages are ingesting the remnants of a degenerating fiber. This is a non-specific myopathic finding.

Neuromuscular junction

Page 22: Musle biopsy

Observations in routine paraffin sections

H & EUsed to evaluate gen architecture of muscle and variation in morphology of individual fibres

•Variation in fascicular architecture•Variation in fiber size•Necrosis and degeneration of muscle fibres•Nuclear characteristics•Type & distribution of inflammatory infiltrate•Interstitial changes

Page 23: Musle biopsy

Architecture of muscle fascicles -scanner view

PATCHY Inflammatory myopathies

FOCAL Neurogenic DIFFUSE Dystrophy

Page 24: Musle biopsy

Nuclear changes

Normal Internalisation of nuclei

Page 25: Musle biopsy

Internalisation of nuclei

• Myotendinous insertion

• Centronuclear myopathy

• Myotonic dystrophy

• Fiber regeneration

• Fiber atrophy

• Chronic neuropathies

Page 26: Musle biopsy

Ring fibres

•Limb girdle dystrophy•Myotonic dystrophy

Page 27: Musle biopsy

Hyaline Fibres

Duchene muscular dystrophy

Page 28: Musle biopsy

Whorled fibres

•Limb girdle muscular dystrophy•Chronic neuropathies

Page 29: Musle biopsy

Pathologic features Disease

Small groups of necrotic fibres

DMD

Perifascicular necrosis Dermatomyositis

Random fibre necrosis PM,IBM

Infarcts with large areas of necrosis

PAN

Extensive,diffuse Rhabdomyolysis

Fibre necrosis seen in biopsy specimen

Page 30: Musle biopsy

Fiber necrosis Perifascicular necrosis

Page 31: Musle biopsy

INCLUSIONS

Nuclear inclusions:Oculopharyngeal dystrophy

Sarcoplasmic Inclusions:Myofibrillar myopathyInclusion body myositis

Page 32: Musle biopsy

Inflammation

Pathologic feature Disease

Perivascular, angiocentric DM, connective tissue disease ,FSHD

Endomysial, aroundfibres

PM, IBM,viral

Nodular Rheumatoid arthritis, granuloma

Polymorphs with eosinophils

PAN, drug reactions, trichinosis, eosinophilicfascitis

Page 33: Musle biopsy

Inflammatory myopathy

Page 34: Musle biopsy

Atrophy

Type 1 fiber atophy Type 2 fiber atophy

•Myotonic dystrophy•Nemaline myopathy•Centronuclear myopathy•Congenital fibre type disproportion

Corticosteroid therapyMyasthenia GravisDisuse AtrophyAcute denervationParaneoplastic myopathy

Pattern of atrophy:Grouped atrophy Chronic neurogenic disordersPanfascicular ISMA(Infantile spinal muscular atrophy)Perifascicular DM(Dermatomyositis)

Page 35: Musle biopsy

Normal Atrophy

Page 36: Musle biopsy

Hypertrophy

Type 1 fiber hypertrophy

Type 2 fiber hypertrophy

Type 1&2 fiber hypertrophy

ISMANormal Atheletes

SprintersCongenital type disproportion

Limb girdle dystrophy,IBM,myotonia congenita,acromegaly

Normal Hypertrophy

Page 37: Musle biopsy

Fiber shape

Normal muscle-polygonalAngular-neurogenic Rounded-myopathic

Page 38: Musle biopsy

Fibre splittingLimb girdle dystrophyIBM

Page 39: Musle biopsy

Cores and targets

Oxidative enzymes are ideal to assess depleted enzyme activityCores : Neurogenic atrophy, central core diseaseTarget fibres: Chronic neuropathies

CORE TARGET

Page 40: Musle biopsy

Central cores Target fibres

Page 41: Musle biopsy

Mottled fibresFSHD

Page 42: Musle biopsy

Nemaline rodsDetected by RTC(Rapid gomori trichome)Seen in Nemaline myopathy

Page 43: Musle biopsy

Mitochondrial Abnormalities

Ragged red fibres(RTC stain)

Page 44: Musle biopsy

Sarcoplasmic vacuoles seen in biopsy specimen

Pathologic feature Disease

In centre arranged in size gradient

Freezing artifact

In scattered fibres ,small round osmiophilic ,oil red O positive

Lipid storage disorders,Mitochondrial myopathies

Often subsarcolemmalPAS +

Glycogen storage

Rimmed, ubiquitin + IBM ,Distal myopathy, OPMD

Page 45: Musle biopsy

Freezing artifact Rimmed Vacuole

Page 46: Musle biopsy

Vacuoles in glycogen storage disease

Page 47: Musle biopsy

Parasite ( Trichenella Spiralis)

Page 48: Musle biopsy

Granulomatous Myositisin a Patient with Sarciodosis

Granulomas tend not to cause significant

damage to adjacent myofibers.

Giant cell

Page 49: Musle biopsy

Pyomyositis Gram Positive Cocci

Page 50: Musle biopsy
Page 51: Musle biopsy

History & examination

History:• Four major pieces of clinical information are critical for the pathologist:• Is the condition a long standing or newly onset condition?• Is the condition progressive or relatively static?• Are there any associated systemic conditions such as heart problem or

autoimmune disease?• What is the serum CPK level?• Other helpful clinical information:• History of myoglobinemia. • Family history of neuromuscular disease.• Sex and age.• Results of EMG studies.• Muscle groups being affected.• Presence of contracture.• Muscle groups being involved.• Site of biopsy.• Therapy and medication at the time of biopsy.

Page 52: Musle biopsy

LAB Investigations:

Creatine kinase level: To rule out certain categories of myopathies because

different myopathies tend to generate a different levels of elevation in CPK.

•High: (e.g. Dystrophinopathies) 200-300 times of normal.

•Intermediate: (e.g. Inflammatory myopathy) 20-30 times of normal.

•Low: (e.g. Neurogenic disorder) 2-5 times of normal.

Page 53: Musle biopsy
Page 54: Musle biopsy
Page 55: Musle biopsy

INHERITEDMuscular dystrophies DMD,BMDFSHDLGDDistal myopathyOPMDMyotonic muscular dystrophyCongenital myopathyCentral core diseaseMulticore diseaseCentronuclearCong fibre type disproportionMyofibtillar myopathyMetabolic diseasesGlycogen storage diseasesMitochondrial diseasesMyoadenylate deficiencyChannelopathies

MyopathiesACQUIREDInflammatory-PM,DM,IBM,granulomatousInfectionsTrichinosis, cyticercosis,toxoplasma,HIV,Coxackie A&BToxicAlcohol, Vit E, OPP, snake venomsDrugsSteroids,statins, b blocker, zidovudin, amiodarone,Chloroquine, chlofibrate,vincristine,cyclosporine,opiatesEndocrine & metabolicHypo/HyperthyroidismAcromegalyCushing`s syndromeConn`s diseaseOsteomalaciaHypercalcemiaHypokalemiaNEOPLASTICBenign-Rhabdomyoma Malignant-RMS

Page 56: Musle biopsy

Muscular dystrophies

•Usually not congenital•Onset in childhood ,young adults•Hereditary diseases ,often with a family history•Weakness frequently severe ,variable distribution•Proximal in DMD,BMD,LGD•Facial in fascioscapulohumeral dystrophy•Distal in distal myopathy MD•Progressive course•Fiber destruction pathological, damage is random ;not all fibers are affected

Page 57: Musle biopsy

Duchenne muscular dystrophy• Inheritance- X- linked recessive disorder

• Defective gene- Dystrophin

• Onset- usually b/n 3-5yrs age

• C/F – progressive weakness of the girdle muscles

- difficulty running , jumping, hopping, unable to get up from the floor (Gower’s maneuver)

-enlargement of muscles of lower leg a/w weakness-Pseudohypertrophy

- contractures( hip, knee, elbow, wrist) with chest deformities →severe pulmonary infections → death at age 16-18yrs

Page 58: Musle biopsy

Others : cardiomyopathy , mental retardationLab. – Serum CK : elevated 20-100x normal

- EMG : myopathic features

- Muscle biopsy- Fiber necrosis & regenerationVariation in fiber size,internalisation of nuclei

proliferation of endomysial connective tissue.Deficiency of dystrophin seen on western blot analysis & immunohistochemical staining.

- DNA analysis : mutation of gene that encodes dystrophin

Page 59: Musle biopsy
Page 60: Musle biopsy

Becker muscular dystrophy• Inheritance – X- linked recessive disorder

• Defective gene – dystrophin

• Onset- experience difficulty b/n 5- 15yrs of age

• C/F – proximal muscles especially of lower extremities are prominently involved.

- hypertrophy of muscles , particularly the calves, is an early & prominent finding.

- cardiomyopathy may occur , MR is less common

• Lab. – CK : elevated

- EMG : myopathic

- muscle biopsy : similar to DMD

: reduced amount or abnormality of dystrophin( Dx)

- DNA analysis : deletions or duplications( Dx)

• Treatment – supportive

• Survival : survive in to the 4th to 5th decade

Page 61: Musle biopsy

Duchene muscular dystrophyWestern Blot

Page 62: Musle biopsy

DMDEnd stages-extensive replacementby adipose tissue andfibrosis

Page 63: Musle biopsy

NORMAL DMD

Page 64: Musle biopsy

Myotonic dystrophy

• Inheritance : AD

• Defective gene: two types with distinct molecular genetic defects

-DM1 : expansion CTG repeat

- DM2 ( proximal myotonic myopathy – PROMM ): CCTG repeat

• C/F – myotonia : usually appears by age 5 yrs

- Hatchet- faced appearance: temporalis , masseter , facial muscle atrophy & weakness

- frontal baldness in men

- foot drop : ankle dorsiflexor weakness

- weakness of wrist extensors , finger extensors, & intrinsic hand muscles

- early involvement of neck muscle flexors, sternocleidomastoids

- dysarthritic speech, nasal voice, swallowing problems due to palatal , pharyngeal, and tongue involvement

- respiratory insufficiency : diaphragm & intercostal muscle involvement

- cardiac disturbances : conduction block with sudden death

: CHF from cor pulmonale 2ry to respiratory failure

Page 65: Musle biopsy

Cont,d

• - other system manifestations : intellectual impairment, hypersomnia, cataract, gonadal atrophy, insulin resistance, reduced esophageal & colonic motility

• Lab. – Dx ; usually based on clinical findings

- CK : N or mildly elevated

- EMG : evidence of myotonia

Biopsy : variation in fiber size,

increase in internal nuclei(chains)

ring fibers, atrophy which

selectively involves type – 1 fibers in 50%

Myotonic dystrophy

Page 66: Musle biopsy

Oculopharyngeal dystrophy

• Inheritance: AD with complete penetrance

• Defective gene: expansion, poly-A-RNA binding protein

• Onset – usually late onset ( 4th – 5th decade )

• C/F – progressive external ophthalmoplegia ( slowly progressive ptosis, limitation of eye movements with sparing of pupillary rxns.

- dysphagia : can be life threatening

: may result in repeated episodes of aspiration

- mild weakness of the neck and extremities

• Lab. – EMG: myopathic features

- CK : 2-3x N

- BIOPSY : distinct features – presence of tubular filaments in muscle

cell nuclei, mild dystrophic changes with

nuclear internalisation ,fiber atrophy,

interstital fibrosis, rimmed vacuoles in type 1 fibres

Page 67: Musle biopsy

Fascioscapulohumeral /FSH/ muscular dystrophy

• Inheritance: AD

• Onset : childhood or young adulthood

• Defective gene: deletion, distal 4q

• C/F- facial weakness: initial manifestation

- weakness of shoulder girdle muscles : weak arm elevation

: scapular winging

- weak wrist extension > wrist flexion

- foot drop : weakness of anterior compartment muscles of the legs

- weakness of the pelvic girdle muscles : 20%

- other organ ( rarely) : labile HTN, nerve deafness

• Lab. – CK : N or elevated

- EMG: myopathic pattern

- BIOPSY: Atrophic muscle fibres in clusters/groups in absence of necrosis,

Moth eaten fibres and perivascular inflammatory infiltrate

Page 68: Musle biopsy

Distal myopathies• Notable for their preferential distal distribution of muscle weakness in contrast to

most muscle conditions associated with proximal weakness

• Four types : mode of inheritance, age of onset, pattern of weakness

1. Welander DM : AD

2. Tibial MD : AD

- late onset, usually after age 40; start in the hands

3. Nonanka DM: AR

4. Miyoshi myopathy : AR

- early onset in late teens or twenties; start in the lower limbs

• Lab. – CK : only slightly elevated except in Miyoshi myopathy-

EMG : myopathic

Biopsy : non- specific dystrophic changes

selective type1 fiber atrophy in welander DM

Page 69: Musle biopsy

Inflammatory and immunemediate myopathies

1.Dermatomyositis2.Polymyositis3.Inclusion body myositis

Page 70: Musle biopsy

Dermatomyositis

• Inflammatory myopathy– Prevalence: 1:100,000 in

general population

– Female to male prevalence of 2:1

– peak incidence ages 40-50

– Immune complex deposition in the vessels considered to be part of a complement-mediated vasculopathy

Hematoxylin and eosin stain (20x) of a muscle biopsy from a patient with dermatomyositisshowing perivascular and perimysial inflammation, as well as perifascicular necrosis.

Page 71: Musle biopsy

Diagnostic Criteria

• Bohan and Peter Criteria:– Symmetric proximal muscle weakness

• most common symptom

– typical rash

– elevated serum muscle enzymes

– myopathic changes on EMG

– characteristic muscle biopsy abnormalities and absence of histopathologic signs of other myopathies

Page 72: Musle biopsy

Grotton’ s Sign: An erythematous, scaly eruption over the extensor surfaces of the metacarpophalangeal joints and digits

Heliotrope rash:A reddish-purple eruption on the upper eyelidaccompanied by swelling of the eyelidMost specific rash in DM

Page 73: Musle biopsy

Dermatomyositis

Perifascicular atrophy

Degeneration

Inflammatory cells in the perimysiumsurrounding a blood vessel

Inflammatory cells tend to be B-cells.

Page 74: Musle biopsy

PolymyositisSymmetrical proximal muscle involvement similar to DMLack of cutaneous involvement,endomyseal inflammatory involvement

Inclusion body myositisInvolvement of distal muscles,esp extensors of knee and flexors of wrist,ASYMMETRICAL

Page 75: Musle biopsy

PM DM IBM

Age at onset >18yrs Adulthood, childhood >50yrs

sex M=F F>M M>F

Weakness proximal proximal Proximal, early distal

involvement

Familial association No No Yes, in some cases

/familial inflammatory

myopathies /

Response to treatment good better poor

CTDs yes yes Yes, in up to 20%

malignacy No yes, in up to 15% of

cases

No

Rash Absent Present Absent

Biopsy “primary” inflammation

with the CD8/MHC-I

complex & vacuoles

Perifascicular,

perymysial, or

privascular infiltrates,

perifascicular atrophy

Primary inflammation with

CD8/MHC-I complex;

vacuolated fibers with

b-amyloid deposits ,

cytochrome oxygenase-

negative fibers ; signs of

chronic myopathy

Page 76: Musle biopsy

POLYMYOSITIS, usually endo-myseal

Page 77: Musle biopsy

INCLUSION BODY MYOSITIS, “rimmed” vacuoles

Page 78: Musle biopsy

Congenital myopathy• Rare disorders distinguished from muscular dystrophies by the presence of specific

histochemical & structural abnormalities in muscle fibers.

• Onset : infancy or childhood

• C/F - progressive muscle weakness ( proximal> distal, legs> arms) & limpness, hypotonia & delayed milestones

- skeletal deformities (kyphoscoliosis, club foot, hip dislocation)

• Lab. - CK: usually N or slightly elevated

- EMG : myopathic/ mostly/; positive sharp waves, myotonic discharges

- Biopsy : features specific to each type

Congenital myopathies

1.Central core disease

2.Multicore disease

3.Nemaline(Rod) myopathy

4.Centronuclear myopathy

5.Congenital fibre type disproportion

6.Myofibrillar myopathy

Page 79: Musle biopsy

Central core disease•AD Ryanodine receptor(RYR1)Gene 19q13.1•Early onset hypotonia, floppy infant,associated skeletal abnormalities,malignant hyperthermia•Biopsy- cytoplasmic cores in type 1Fibres(NADH-TR stain)

Page 80: Musle biopsy

Multicore disease

•Cong non progressive myopathy(gen weakness,hypotonia)

•Biopsy –type 1 fiber predominance& minute core like structures in majority of fibres

Page 81: Musle biopsy

Nemaline (Rod)myopathy•AR/AD•Childhood weakness•Ebbing of strength is more in facial & proximal limb muscle•Facial dysmorphism•Aggregates of subsarcolemmal spindle shaped particles(nemaline rods) occuringpredominantlyIn type 1 fiber best seen RTC stain

Page 82: Musle biopsy

Myotubular/Centronuclearmyopathy

•AD/AR/XL•MTM 1 gene(Xq27-28) XL•Clinical findings-severe congenital hypotoniaFloppy infants, poor prognosis, extraocular

palsies & facial asthenia occur

simultaneously with involvement of

appendicular muscle•BIOPSY- Abundance of centrally located nuclei involving majority of muscle fibres(mostly in type1 fibres)

Page 83: Musle biopsy

Congenital fibre type disproportion

•Atrophy of type 1 fibres, hypertrophy of type 2 fibres•Detectable at birth, paucity of motor activity & diminished tone•Muscle deterioration tends to continue throughout first decade& then ceases or undergo reversal•Skeletal deformities-hip dislocation ,kyphoscoliosis ,joint contractures

Page 84: Musle biopsy

Myofibrillar myopathies

•Heterogenous group of disorders(protein surplus myopathies)•Accumulation of intermediate filaments including desmin,actin,myosin,ab crystalline & myomotilin within fibres•Adult onset•Distal weakness,dysphagia & cardiac involvement

Desmin myopathy (RTC)

Page 85: Musle biopsy

General questions to keep in mind during reporting muscle biopsy

• Are the muscle fibres abnormal??

• Is the pathologic process-neurogenic/myopathic??

• What is the distribution of pathology??

• Are there any diagnostic features??

Page 86: Musle biopsy

Are the muscle fibers abnormal??

Size-small or large

Shape-rounded or angular

Type-grouping, fiber predominance

Internal architecture-disordered/lost, vacuoles,Internal nuclei, inclusions

Storage/acumulated material-glycogen, lipid, mitochondria

Is the pathologic process

NEUROGENIC/MYOGENIC

• Shape of muscle fibers

ROUND Myopathic

ANGULAR Neurogenic

Page 87: Musle biopsy

• Distribution of atophic fibers

Grouped-Denervation ,dystrophinopathies

Scattered-Acute neuropathy or myopathy

ACUTE OR CHRONIC

Acute:

Myopathy-Muscle fiber regeneration &denevation

Neuropathy-Small angular muscle fibers

Chronic:

Myopathy-increased endomysial connective tissue, muscle fiber hypertrophy

Neuropathy-fiber type grouping ,pyknotic nuclear clumps

Page 88: Musle biopsy

• What is the distribution of the pathology??UNIFORM-Dystrophy, fiber type predominance

REGIONAL

Patchy fascicular changes-inflammatory myopathies,focal denervation

Group of muscle fibers

Neuropathy -Progressive denervation with reinnervation

Myopathy- Myopathic grouping, perifascicular atrophy

SCATTERED muscle fibers: Acute myopathy, Acute neuropathy

• Are there diagnostic feaures??INFLAMMATION

SITE

STORAGE MATERIAL

PATHOLOGY other than muscle fibers

Page 89: Musle biopsy

References Vinay Kumar,Abul.Kabbas,Nelson Fausto. Robbins & Cotran

Pathological Basis of Disease.8th ed. Chicago,Illinois:Elsevier.2010 .p. 905-969

Stephen S sternburg, Donald A.A,Daryl. Carter,Stacey.E, ObermanH.A. Diagnostic Surgicl Pathology.3rd ed. Newyork: LippincortWilliams &Wilkins;1999.p.1701-1784.

C. Sundaram and Megha S.Uppin,Approach to the interpretation of muscle biopsy ,Nizam institute of medical sciences, Hyderabad.

Ivan Damjanov,Anderson`s Pathology.10th

ed.Kansas:Elsevier;2009.Vol2.p2653-2692.

WellerR.O.Systemic Pathology,Nervous system,muscle & eyes.3rd

ed/vol4.Chuechill Livingston;1990.p.580-665.

Page 90: Musle biopsy